HOME >> BIOLOGY >> NEWS
Lens replacement material may improve cataract treatment, eliminate bifocals

New York, Sept. 8, 2003 -- Scientists at the Veterans Affairs (VA) Hospital and Washington University School of Medicine in St. Louis are developing a gel-like material that eventually could be used to replace diseased and aging lenses in the eyes of patients with cataracts. The material also might eventually mean the end of bifocals and contact lenses for millions of people who suffer from presbyopia -- literally "old vision" -- a condition that makes it difficult for people over 40 to read without magnification.

The researchers described their work in New York at the 226th national meeting of the American Chemical Society, the world's largest scientific society.

"This could represent a totally different approach to the treatment of cataracts and presbyopia," says Nathan Ravi, M.D., Ph.D., principal investigator, associate professor of ophthalmology and visual sciences and professor of chemical engineering at Washington University in St. Louis. "As we age, the lens of the eye gradually loses its ability to adjust its focus. We have demonstrated that this gel has similar mechanical properties to the lens of the eye, and we hope it also will be able to perform the visual functions of the natural lens."

Ravi, who also is director of ophthalmology for VA Heartland hospitals in the Midwest, has been working with various synthetic polymers, looking for those that compare favorably with the natural lens. His research centers on understanding the biomechanics of the lens and the causes of presbyopia.

As we age, the tissues in our eyes tend to lose their flexibility. The lens also becomes cloudy if cataracts form. The current treatment for cataracts is to remove the old lens material and replace it with a flexible plastic lens. The new strategy would be to carefully remove the aging and clouded lens material from the lens' capsular bag (the part of the eye that holds the lens), while leaving that structure intact. Then, the surgeon would
'"/>

Contact: Jim Dryden
drydenj@msnotes.wustl.edu
314-286-0110
Washington University School of Medicine
8-Sep-2003


Page: 1 2 3

Related biology news :

1. Innovative ceramic-on-metal hip replacements to undergo clinical trials
2. Growing replacement teeth and dental tissues
3. NIH consensus panel confirms effectiveness of total knee replacement
4. Standard helps control quality of joint replacements
5. New national studies show combined hormone replacement therapy boosts stroke, dementia
6. The timing of hormone replacement therapy could be key to success
7. A new twist on an age-old problem: Making knee replacements last
8. New study promises safer hormone replacement therapy
9. Hormone replacement therapy may improve breast cancer detection and survival rate
10. Hormone replacement therapy may help prevent heart vessel disease, says Wake Forest researcher
11. Hormone replacement therapy may help prevent chronic wounds in elderly patients

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/18/2019)... ... March 18, 2019 , ... uBiome, ... industry and the third highest quality portfolio following Seres Health and Nestle, as ... Christian Moser, and Theodor Myfleler. uBiome executives Dr. Jessica Richman, PhD, co-founder and ...
(Date:3/14/2019)... , ... March 13, 2019 , ... Bode Technology (Bode), a leading provider ... on more than 100,000 sexual assault kits. As thousands of untested kits are identified ... sexual assault kit backlogs . Bode has tested more than 50,000 kits in the ...
(Date:3/12/2019)... SANTA CLARA, Calif. (PRWEB) , ... March 12, ... ... world leader in strong multi-factor authentication and combined technology all-in-one smart cards, announced ... combined with FIDO strong authentication: the Fingerprint Biometric and Dynamic CVV Payment cards. ...
Breaking Biology News(10 mins):
(Date:3/19/2019)... WHITEHOUSE, N.J. (PRWEB) , ... March 19, 2019 , ... ... and is a great opportunity to see the most cutting-edge cancer research. The Visikol ... work with 3D cell culture assays as well as their digital ...
(Date:3/19/2019)... ... ... will review strategies for data management in modular and adaptive clinical trials. , Participants will:, ... 30 percent, reducing cost while increasing quality, achieving clinical site set-up faster , ... reducing risk and impact on trial success, trial teams, and trial execution , ...
(Date:3/15/2019)... (PRWEB) , ... March 15, ... ... of 100% equity in American Process Inc. and affiliate companies including AVAPCO ... Biorefinery in Alpena Michigan, the Thomaston Biorefinery and R&D center in Thomaston, ...
(Date:3/14/2019)... DESERT, Calif. (PRWEB) , ... March 14, 2019 ... ... issued a press release announcing that its Canadian partner, the Eye Machine Canada ... Canada, using Nova Oculus’s pioneering technology for treating Age-Related Macular Degeneration (AMD). , ...
Breaking Biology Technology:
Cached News: